Myanmar Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials
• Forums

Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar
Conditions:   Drug Resistance;   Plasmodium Falciparum MalariaIntervention:   Drug: First line antimalarial in Myanmar (artemether-lumefrantrine, dihydroartemisinin-piperaquine, and artesunate-mefloquine)Sponsors:   Department of Medical Research, Lower Myanmar;   Kangwon National UniversityCompleted - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2016 Category: Research Source Type: clinical trials